IHL News: Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement - 27th Jul 2022, 9:55pm

[annb0t]

MELBOURNE, Australia, July 27, 2022 /PRNewswire/ -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), ('Incannex' or the 'Company'), is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 June 2022. Incannex is undertaking a multitude of U.S. Food and Drug Administration ('FDA') programs for cannabinoid pharmaceutical products and psychedelic medicine therapies administered by health professionals.
...

>>> Read more: Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement